(Q41878340)

13 October 2017

Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients (English)

1 reference

13 October 2017

gastric adenocarcinoma

1 reference

Deng Luo

1

1 reference

13 October 2017

Ting Ye

2

1 reference

13 October 2017

Tian-Qian Li

3

1 reference

13 October 2017

Peng Tang

4

1 reference

13 October 2017

Sha-Dong Min

5

1 reference

13 October 2017

Gong-Fang Zhao

6

1 reference

13 October 2017

Hua Huang

7

1 reference

13 October 2017

Jiang Chang

8

1 reference

13 October 2017

Yan Wang

9

1 reference

13 October 2017

Lin Lv

10

1 reference

13 October 2017

Ming-Liang Lu

11

1 reference

13 October 2017

Meng-Yao Zheng

12

1 reference

13 October 2017

28 December 2011

1 reference

Experimental and Therapeutic Medicine

13 October 2017

1 reference

13 October 2017

3

1 reference

13 October 2017

3

1 reference

13 October 2017

391-396

1 reference

Cancer epigenetics reaches mainstream oncology

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Methylation of DNA in cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Genomic and genetic alterations influence the progression of gastric cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Epigenetic aberrations during oncogenesis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Genetic and epigenetic alteration in gastric carcinogenesis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

The Ras effector RASSF2 controls the PAR-4 tumor suppressor

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

5 June 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Cancer survival in Tianjin, China, 1991-1999.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Cancer survival in Shanghai, China, 1992-1995.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Cancer survival in Hong Kong SAR, China, 1996-2001.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Prognostic analysis of familial gastric cancer in Chinese population.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

7th Edition of the AJCC Cancer Staging Manual: Stomach

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Activation of RASSF2A by p300 induces late apoptosis through histone hyperacetylation

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

Nuclear transport of Ras-associated tumor suppressor proteins: different transport receptor binding specificities for arginine-rich nuclear targeting signals.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438690

[TNM-7th edition 2009 (UICC/AJCC) and Japanese Classification 2010 in Gastric Cancer. Towards simplicity and standardisation in the management of gastric cancer]

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22969901

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

An overview of the cancer burden for primary care physicians

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22969901

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cancer survival in Qidong, China, 1992-2000

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22969901

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3892/ETM.2011.440

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

22969901

1 reference